In patients hospitalized for COVID-19, does dexamethasone reduce 28-days mortality compared to standard treatment?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
|---|---|
| Enthalten in: |
La Revue de medecine interne - 41(2020), 11 vom: 19. Nov., Seite 790-791 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Chez les sujets hospitalisés pour COVID-19, est-ce que la dexaméthasone diminue la mortalité à 28jours comparativement au traitement standard ? |
|---|
| Beteiligte Personen: |
Lanthier, L [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 17.12.2020 Date Revised 29.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.revmed.2020.08.005 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM316465984 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM316465984 | ||
| 003 | DE-627 | ||
| 005 | 20240329235855.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.revmed.2020.08.005 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1355.xml |
| 035 | |a (DE-627)NLM316465984 | ||
| 035 | |a (NLM)33077267 | ||
| 035 | |a (PII)S0248-8663(20)30348-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Lanthier, L |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a In patients hospitalized for COVID-19, does dexamethasone reduce 28-days mortality compared to standard treatment? |
| 246 | 3 | 3 | |a Chez les sujets hospitalisés pour COVID-19, est-ce que la dexaméthasone diminue la mortalité à 28jours comparativement au traitement standard ? |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.12.2020 | ||
| 500 | |a Date Revised 29.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
| 650 | 7 | |a Dexamethasone |2 NLM | |
| 650 | 7 | |a 7S5I7G3JQL |2 NLM | |
| 700 | 1 | |a Mayette, M |e verfasserin |4 aut | |
| 700 | 1 | |a Huard, G |e verfasserin |4 aut | |
| 700 | 1 | |a Plourde, M-É |e verfasserin |4 aut | |
| 700 | 1 | |a Cauchon, M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t La Revue de medecine interne |d 1983 |g 41(2020), 11 vom: 19. Nov., Seite 790-791 |w (DE-627)NLM012660108 |x 1768-3122 |7 nnns |
| 773 | 1 | 8 | |g volume:41 |g year:2020 |g number:11 |g day:19 |g month:11 |g pages:790-791 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.revmed.2020.08.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 41 |j 2020 |e 11 |b 19 |c 11 |h 790-791 | ||